BBB Weight Loss Program

Semaglutide & Tirzepatide Weight Loss in Corona, CA

A physician-supervised GLP-1 program that pairs once-weekly semaglutide or tirzepatide with lab work, nutrition coaching and weekly check-ins, so the weight you lose stays off.

  • Physician-led by Dr. Heidi Choi, MD
  • FDA-approved medications
  • In-office or remote check-ins
  • The Shops at Dos Lagos, Corona
Smiling woman holding a bathroom scale, celebrating progress in the BBB Weight Loss Program in Corona, CA
2

FDA-approved GLP-1 medications

Semaglutide (Wegovy®, approved for weight management in 2021) and tirzepatide (Zepbound®, approved in 2023), prescribed only after a provider evaluation.

15–21%

Average weight loss in clinical trials

14.9% at 68 weeks with semaglutide (STEP 1) and 20.9% at 72 weeks with tirzepatide 15 mg (SURMOUNT-1). Individual results vary.

Weekly

Check-ins with our medical team

A 4-to-6-month program with gradual dose adjustments and coaching, in person at our Corona office or remotely from home.

What is semaglutide, and how does it help you lose weight?

Semaglutide is a once-weekly injectable medication that mimics GLP-1, a gut hormone that tells your brain you are full, slows stomach emptying and steadies blood sugar. The result is a quieter appetite: you feel satisfied with less food, and cutting calories stops feeling like a fight.

Semaglutide (Wegovy®) has been FDA-approved for chronic weight management since 2021. In the 68-week STEP 1 trial, adults taking 2.4 mg once weekly lost an average of 14.9% of their body weight, compared with 2.4% on placebo (Wilding et al., NEJM, 2021).

Tirzepatide (Zepbound®), approved for weight management in 2023, activates two gut-hormone receptors, GIP and GLP-1. In the 72-week SURMOUNT-1 trial, adults on the 15 mg dose lost an average of 20.9% of their body weight (Jastreboff et al., NEJM, 2022).

Both medications work best alongside better eating habits and regular movement, which is why our program includes coaching and weekly check-ins, not just a prescription. Individual results vary, and both are prescribed at Beautiful Body and Beyond only after a provider evaluation.

Semaglutide, the active ingredient in Ozempic and Wegovy, offered through the Beautiful Body and Beyond weight-loss program
Semaglutide vs. tirzepatide

Which medication is right for you?

Both are once-weekly injections that curb appetite, and both are offered in the BBB Weight Loss Program. Semaglutide activates one receptor (GLP-1); tirzepatide activates two (GIP and GLP-1), which is the main reason trial participants lost more weight on it on average. Your provider recommends one based on your health history, your goals and how you tolerate each medication.

Semaglutide Tirzepatide
Brand names Wegovy (weight), Ozempic (diabetes) Zepbound (weight), Mounjaro (diabetes)
How it works GLP-1 receptor agonist Dual GIP + GLP-1 receptor agonist
FDA approval for weight management 2021 2023
Average weight loss in pivotal trial 14.9% at 68 weeks (STEP 1) 20.9% at 72 weeks, 15 mg dose (SURMOUNT-1)
Dosing Once-weekly injection, increased gradually Once-weekly injection, increased gradually
Common side effects Nausea, constipation, diarrhea, usually easing over time Nausea, diarrhea, decreased appetite, usually easing over time

Am I a candidate?

GLP-1 medications are generally considered for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea.

They are prescription medicines, and they are not right for everyone:

  • They are not used during pregnancy, while breastfeeding or while trying to conceive.
  • A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 rules them out.
  • A history of pancreatitis, certain gastrointestinal conditions and some other medications need review first.

The only way to know for sure is a medical evaluation. At your complimentary consultation our provider reviews your health history and current medications, orders lab work and, if you qualify, builds a plan that pairs the medication with nutrition and lifestyle support.

Check My Eligibility

Medical provider measuring a patient's waist during a weight-loss consultation

What the BBB Weight Loss Program includes

Medication alone is not a plan. Every client in the program receives:

  • A provider evaluation and lab work to confirm you are a candidate and to choose between semaglutide and tirzepatide.
  • A once-weekly injection with a gradual dose increase to limit side effects, self-administered at home or given in our office.
  • Nutrition and exercise coaching built around whole foods, adequate protein and an activity plan you can keep.
  • Weekly check-ins, in person at our Corona office or remotely, to track progress and adjust your plan.
  • A maintenance plan at the end of your 4-to-6-month program, because lasting weight loss depends on habits, not the medication alone.

Every treatment plan is overseen by our medical director, Dr. Heidi Choi, MD, at The Shops at Dos Lagos in Corona, CA.

Confident woman in a tailored coat walking through a doorway, representing the confidence that comes with reaching a weight-loss goal
How the program works

Four steps to a lighter, healthier you

Proven medication, expert guidance and lab-based monitoring, combined into a plan that fits your life.

Complimentary consultation

Tell us about your goals, your health history and what you have tried before. No pressure, no obligation.

Provider evaluation and labs

A licensed provider reviews your medications, orders lab work and confirms whether semaglutide or tirzepatide is appropriate for you.

Start your program

Begin your once-weekly injection at a low dose that is increased gradually, with nutrition and activity coaching from day one.

Weekly check-ins

Track progress, manage side effects and adjust your plan every week, in the office or remotely, then transition to a maintenance plan.

Complimentary consultation

Your weight-loss journey starts with a conversation.

Meet with our medical team, review your health history and find out whether semaglutide or tirzepatide is right for you.

Ask about our new-client bonus package, valued at over $2,200.

Good to know

Frequently asked questions

Still have a question?
What is the BBB Weight Loss Program?
The BBB Weight Loss Program is a physician-supervised 4-to-6-month program that pairs a once-weekly GLP-1 injection (semaglutide or tirzepatide) with nutrition and exercise coaching. It includes a provider evaluation, lab work and weekly check-ins, which you can do in person at our Corona office or remotely from home.
How does semaglutide help with weight loss?
Semaglutide mimics GLP-1, a gut hormone that acts on the appetite centers of the brain and slows stomach emptying. You feel full sooner and stay satisfied longer, so you naturally eat less. In the 68-week STEP 1 trial, adults taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight, compared with 2.4% on placebo (Wilding et al., NEJM, 2021).
Who qualifies for the BBB Weight Loss Program?
GLP-1 medications are generally considered for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea. They are prescription medicines and are not right for everyone: they are not used during pregnancy or while trying to conceive, and a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 rules them out. A history of pancreatitis, certain gastrointestinal conditions and some other medications also need review. The only way to know is a medical evaluation, which is what your complimentary consultation is for.
How is the medication administered?
Both semaglutide and tirzepatide are given as a once-weekly subcutaneous injection with a very small needle, usually in the abdomen or thigh. We show you how to self-administer at home, or you can come to the office for your weekly dose. The dose starts low and increases gradually to limit side effects.
How soon will I see results?
Many clients notice a quieter appetite within the first two weeks. Meaningful weight loss builds over months as the dose increases: the pivotal trials ran 68 weeks (semaglutide) and 72 weeks (tirzepatide). Results vary from person to person, and they depend on the nutrition and activity habits the medication makes easier to keep.
What are the side effects?
The most common side effects are nausea, constipation, diarrhea and reduced appetite, which usually ease as your body adjusts to each dose. Less common but serious risks include pancreatitis and gallbladder problems, which is why we screen your history first and check in weekly. Report severe or persistent abdominal pain to your provider right away.
How is tirzepatide different from semaglutide?
Both are once-weekly injections that curb appetite, and both are offered in the BBB Weight Loss Program. Semaglutide activates one gut-hormone receptor (GLP-1); tirzepatide activates two (GIP and GLP-1), which is the main reason trial participants lost more weight on it on average (20.9% at 72 weeks in SURMOUNT-1 versus 14.9% at 68 weeks in STEP 1). Your provider recommends one based on your health history, goals and tolerance. See the comparison table above for details.
Do I have to come into the office every week?
No. Weekly check-ins can be done in person at our Corona office or remotely by phone or video. Your initial consultation and lab work are done in person.
Can I combine the weight-loss program with body contouring?
Yes. Many clients treat stubborn pockets that remain after weight loss with CoolSculpting Elite, or tighten loose skin with Evolve. We usually recommend waiting until your weight has stabilized so the contouring results last.
Testimonials

Google Reviews

This page is for educational purposes and is not medical advice. Semaglutide and tirzepatide are prescription medications that are not right for everyone; a licensed provider reviews your health history and lab work to determine whether you are a candidate. Individual results vary. Wegovy®, Ozempic®, Zepbound® and Mounjaro® are registered trademarks of their respective manufacturers.